FDA-Approved Medications to Treat Tardive Dyskinesia
Dec 17, 2019 · Two medications are FDA-approved to treat tardive dyskinesia, and new long-term evidence has been reported. Follow along as expert Joseph P. McEvoy, MD, reviews the …
List of 22 Tardive Dyskinesia Medications Compared - Drugs.com
Mar 5, 2024 · Compare risks and benefits of common medications used for Tardive Dyskinesia. Find the most popular drugs, view ratings and user reviews.
Valbenazine (Ingrezza): The First FDA-Approved Treatment for Tardive …
Abstract Valbenazine (Ingrezza): the first FDA-approved treatment for tardive dyskinesia INTRODUCTION Tardive dyskinesia (TD) is a spectrum of hyperkinetic movement disorders …
Treatment Strategies for Tardive Dyskinesia - U.S. Pharmacist
May 14, 2025 · Two vesicular monoamine transporter 2 inhibitors, valbenazine and deutetrabenazine, are FDA approved for the treatment of TD. These medications are generally …
Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia …
May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.
FDA Approves One Pill, Once-Daily Tablets of Deutetrabenazine …
May 30, 2024 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia …
FDA approves new doses of Austedo XR for tardive dyskinesia
Jun 3, 2024 · The FDA has approved Austedo XR in four new tablet strengths for adults diagnosed with tardive dyskinesia and chorea associated with Huntington’s disease, according …
Valbenazine Phase 3 Study Confirms Safety, Efficacy for Tardive Dyskinesia
Jun 4, 2024 · The US Food and Drug Administration (FDA) first approved valbenazine (Ingrezza) in 2017 as a once-daily selective vesicular monoamine transporter 2 (VMAT2) inhibitor for …
FDA approves first drug to treat tardive dyskinesia | FDA
The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.
Tardive Dyskinesia Treatment Guidelines: An Overview
Explore tardive dyskinesia treatment guidelines, including FDA-approved meds, off-label options, and PGx testing for better outcomes.